Male Pelvic Health following Pelvic Surgery

Similar documents
A Proposed Study of Hyperbaric Oxygen Therapy Following Radical Prostatectomy: Effects on Erectile Dysfunction

Management of Post-Prostatectomy Urinary Incontinence and Sexual Dysfunction

Managing Erectile Dysfunction

MALE SEXUAL DYSFUNCTION. Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara

Managing the Patient with Erectile Dysfunction: What Would You Do?

Defined as the consistent inability to attain and maintain an erection adequate for sexual intercourse Usually qualified by being present for several

Erectile Dysfunction; It s Not Just About Sex

ERECTILE DYSFUNCTION DIAGNOSIS

Erectile Dysfunction: A Primer for Primary Care Providers

Disclosure Slide. Dr Michael Gillman IMPOTENCE ERECTILE DIFFICULTIES. Do Men Really Care??? 15/10/2014 ASSESSMENT OF ERECTILE DYSFUNCTION

Canadian Undergraduate Urology Curriculum (CanUUC): Erectile Dysfunction

, David Stultz, MD. Erectile Dysfunction. David Stultz, MD September 10, 2001

GUIDELINES ON ERECTILE DYSFUNCTION

With My Heart, Can or Should I Take Erectile Dysfunction Drugs?

Penile Rehabilitation after Radical Prostatectomy

ERECTILE DYSFUNCTION TREATMENTS

for ED and LUTS/BPH Pierre Sarkis, M.D. Assistant Professor Fellow of the European Board of Urology

Erectile dysfunction. By Anas Hindawi Supervised by Dr Khalid AL Sayyid

XVII Congresso Regionale A.R.C.A Holiday Inn ROMA 22 settembre 2017 TREATMENT OF ERECTILE DYSFUNCTION: THE ROLE OF INTERVENTIONAL CARDIOLOGY

Clinical evaluation of Tentex forte and Himcolin cream in the treatment of functional erectile dysfunction

MANAGEMENT UPDATE , LLC MedReviews

GUIDELINES ON ERECTILE DYSFUNCTION

ASSESSMENT OF PREMATURE EJACULATION AND ERECTILE DYSFUNCTION

Schemi terapeutici complessi per la gestione della disfunzione erettile post trattamento del carcinoma prostatico: non solo PDE5i

Erectile Dysfunction (ED) Shawn McGee M.D. CentraCare Adult and Pediatric Urology January 30 th, 2016

13-Oct-15 ERECTILE DYSFUNCTION. Urology Subdepartement dr. Mintohardjo Naval Hospital dr. Isdiyanto Septiadi, Sp.U

Life after prostate cancer End your frustration. Restore your normalcy. Renew your confidence. Take the next step

THE FACTS ABOUT MEN S SEXUAL HEALTH

Diagnosis and management of sexual dysfunction. Dr Chris Simpson Consultant Psychiatrist

김준철 가톨릭대학교의과대학비뇨기과학교실

IC351 (tadalafil, Cialis): update on clinical experience

Find your ED cure End your frustration. Renew your confidence. Feel complete. Take the next steps. Erectile dysfunction and heart disease

ERECTILE DYSFUNCTION. Prof. Khan Abul Kalam Azad. Head, Department of Medicine, Dhaka Medical College President, Bangladesh Society of Medicine

Overview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014

ERECTILE DYSFUNCTION. & Current Therapies. GP Conference, Rotorua 7-10 June 2012

Sex and the prostate. Before starting treatment. WHO declaration - sexual health 05/12/2013

Ian Eardley Department of Urology, Leeds Teaching Hospital Trust

Quality of life issues after treatment for prostate cancer

Patient Information ERECTILE DYSFUNCTION. Department of Urology

Jan Farrell. Nurse Consultant Urology Department of Urology Rotherham General Hospital NHS FT

Assessment of Erectile and Ejaculatory Function after Penile Prosthesis Implantation

ED treatments: PDE5 inhibitors, injections and vacuum devices

Sexuality and Bone Marrow Failure Diseases: A Conversation

Erectile dysfunction as a predictive factor for coronary artery disease

Erectile Dysfunction Medical Treatment

Erectile Dysfunction and the Prostate Cancer Patient

Summary. Neuro-urodynamics. The bladder cycle. and voiding. 14/12/2015. Neural control of the LUT Initial assessment Urodynamics

Is This Really a Fair Debate? 2013 MFMER slide-2

MEDICAL POLICY SUBJECT: ERECTILE DYSFUNCTION. POLICY NUMBER: CATEGORY: Miscellaneous

Opinion: Yes. PDE-5 inhibitors should be used post radical prostatectomy as erection function rehabilitation?

University of Alberta Reconstructive Urology Fellowship

2017 Hospital Coding and Payment Guide

Sidney Glina Faculdade de Medicina do ABC Instituto H. Ellis Editor-in-Chief of the International Brazilian Journal of Urology

Erectile dysfunction as an early sign of cardiovascular disease

Testosterone and PDE5 inhibitors in the aging male

Clinical Case Reports: Open Access

Central hemodynamics and prediction of cardiovascular events in patients with erectile dysfunction

Evidence Review for Surrey Prescribing Clinical Network. Treatment: Oral and non-oral combination therapy for erectile dysfunction

Clinic for urology, pediatric urology and andrology. Penile diseases. Dr. Arne Hauptmann

Sexual function and dysfunction in men

EAU GUIDELINES ON MALE SEXUAL DYSFUNCTION: Erectile Dysfunction and Premature Ejaculation

GUIDELINES ON MALE SEXUAL DYSFUNCTION: Erectile Dysfunction and Premature Ejaculation

Jan Farrell Nurse Consultant Urological Services Department of Urology Rotherham General Hospital NHS FT

Sexual Health in Older Adults

Penile Implant Should be Offered Early

Life after prostate cancer. End your frustration. Restore your normalcy. Renew your confidence. Erectile dysfunction and male incontinence

Understanding your treatment options for male stress urinary incontinence and erectile dysfunction

Mr PHIP No. 6 Sexual function after treatment for prostate cancer

Prostate cancer. Treatments Side effects and management in the community setting

P ROLIEVE. Thermodilatation System. The Prolieve System Patient Information is Directed to You, the Patient. A Transurethral Microwave Therapy Device

Sexual Function for Men with Spinal Cord Injury

Penile implants What to expect and how to prepare

I-STOP TOMS Transobturator Male Sling

Physiology and disturbances of sexual functions Prof. Jolanta Słowikowska-Hilczer, M.D., Ph.D.

Urinary tract disorders

** REGULATORY ALERT **

Neurogenic bladder. Neurogenic bladder is a type of dysfunction of the bladder due to neurological disorder.

This Special Report supplement

flow resulting from damage to blood vessels can also contribute to sexual dysfunction.

ERECTION MISDIRECTION: PENILE REHABILITATION & TREATMENTS FOR ERECTILE DYSFUNCTION. Gregory Harochaw Pharmacy Manager Tache Pharmacy (204)

6.2 Elements for a Public Summary

Sexual Dysfunction Caused by Cancer Treatments Issues in Men. Dr Christopher Love

International Journal of Intellectual Advancements and Research in Engineering Computations

Various Types. Ralph Boling, DO, FACOG

MODULE 4: ERECTILE DYSFUNCTION

Diagnosis and management of Peyronie s disease: an evidence-based review

GUIDELINES ON NEURO-UROLOGY

If you have erection problems, ask your doctor about treatments that could help you.

Product Name or Headline

How to select the right patient for the right treatment: What role does sexuality play in Pca treatment?

Unstable angina following intracavernous injection of alprostadil: a case study

The effect of sildenafil on electrostimulation-induced erection in the rat model

Managing Symptoms after Prostate Cancer Sexual Side Effects. Changes in a man s sex life are common and can be managed.

Men s Health Coding & Payment Quick Reference

Erectile dysfunction (ED) is the inability to obtain or maintain an erection satisfactory

NHS Dumfries & Galloway Erectile Dysfunction Audit October 2010

Sexual Health after Spinal Cord Injury

Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil

Sexual Health and Dysfunction in the Elderly. Nadya S. Dávila Lourido, MD September 28, 2018

Transcription:

Male Pelvic Health following Pelvic Surgery

Radical Pelvic Surgery Associated Sexual Dysfunction Pathophysiology

Post Radical Prostatectomy (RP) Sexual Dysfunctions Erectile dysfunction (ED) Anejaculation Anorgasmia Dysorgasmia (painful ejaculation) Orgasm associated urine leak Penile length alterations Penile curvature

Sexual Health A fundamental human right Important to overall health and quality of life Satisfaction provides many benefits to patients and their partners Proceedings of a Regional Consultation convened by Pan American Health Organization (PAHO). World Health Organization (WHO) in collaboration with the World Association for Sexology (WAS). May 19-22, 2000; Antigua Guatemala, Guatemala.

Sexual Dysfunction Characterized by disturbances in sexual desire and in the psychophysiologic changes associated with the sexual response cycle Causes personal distress or interpersonal difficulty May signal the presence or progression of underlying disease (eg, cardiovascular disease [CVD], heart disease, vascular insufficiency, depression) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994. Jackson G, et al. Int J Clin Pract. 1999;53:445-451. Nicolosi A, et al. Urology. 2013;61:201-206.

Definition of ED the consistent or recurrent inability of a man to attain and/or maintain a penile erection sufficient for sexual performance Recommendations of the 1st International Consultation on Erectile Dysfunction. In: Jardin A, et al, eds. Erectile Dysfunction. Plymouth, United Kingdom: Health Publication, Ltd; 2000:711-726.

Physiology of Normal Erections Erections are a complex event, requiring Intact arterial and venous system Normal innervation Normal hormonal factors Functioning erectile tissue (the penis) Abnormalities in any or all of these will lead to ED.

Physiology of Normal Erections Nerve signals Release of nitric oxide Smooth muscle relaxation in capillary bed of corporal bodies Increase in blood flow, filling penis Draining veins compressed Normal Erection

ED and CVD Penile vascular bed is unique, with smaller vessels feeding it 57% of men in one study who had had bypass surgery had prior ED 64% of men in one study hospitalized for myocardial infarction (MI) had experienced prior ED ED is a likely indicator of systemic vascular disease and probably an early warning for increased risk of MI or stroke Gundle MJ, et al. Am J Psychiatry. 1980;137:1591-1594. Jackson G, et al. Int J Clin Pract. 1999;53:363-368. Marwick C. JAMA. 1999;281:2173-2174. Pritzker MR. Abstract presented at: Proceedings of the American Heart Association; November 7-10, 1999; Atlanta, Ga. Abstract 104561. Wabrek AJ, et al. Arch Sex Behav. 1980;9:69-77.

Percent ED May Be Clinically Evident Prior to CAD Symptoms Among 300 patients with CAD and angina All ED Severe ED Prevalence of ED among patients was 49% Mean time between onset of ED symptoms and onset of CAD is 38.8 months (range 1-168) 60 50 40 30 20 ED symptoms prior to CAD All patients with type 1 diabetes had ED prior to CAD 10 0 CAD=coronary artery disease Montorsi F. Eur Urol. 2013;44:360-364.

Relationship of ED to Silent MI in Type 2 Diabetes 133 men with type 2 diabetes and documented asymptomatic CAD were compared with 127 men with type 2 diabetes and negative cardiac evaluation ED was highly correlated with the presence of asymptomatic silent MI and CAD Men with type 2 diabetes who present with ED and no cardiac history need cardiac evaluation Gazzaruso C, et al. Circulation. 2014;110:22-26.

ED as a Predictor of Heart Attack In a study of >25,000 men Men with ED had almost twice the risk of heart attack vs men without ED Men aged >40 years with ED had 3 to 4 times the risk of heart attack vs younger (aged 30-39) cohort 13 11 9 7 5 3 1 Odds Ratio (95% CI) 3.8 4.0 1.99 Total Aged 40-44 Aged 50-55 Blumentals WA. Int J Impot Res. In press. February 26, 2004. Available at: http://www.nature.com/cgi-taf/dynapage.taf?file=/ijir/journal/vaop/ncurrent/abs/3901309a.html.

Is ED a Sentinel of Early Atherosclerosis? 45 men with ED but no vascular risk factors (VRFs), 45 men with ED and VRFs, 25 healthy men (aged 25-67 years) Measures Endothelial cell activation proteins (ECA), P-selectin, intercellular adhesion molecule, vascular cell adhesion molecule-1, endothelin Vascular injury assessed by ultrasound intima-media thickness of carotid arteries and pharmacologically stimulated peak systemic velocity of cavernous arteries Results after correcting for body mass index (BMI) and smoking Elevated ECAs in men with ED compared with controls (P<0.01) Endothelin is best predictor for ED Vascular studies show no damage in those with ED and no VRFs Increase in ECAs associated with ED independent of VRFs and overt vascular damage ED is sentinel of early atherosclerosis Bocchio M, et al. J Urol. 2004:171:1609-1610.

Causes of ED: Neurogenic Factors Radical pelvic surgery 1-3 Pelvic/spinal cord injury 1-3 Multiple sclerosis or other demyelinating conditions 3 Neuropathies 1-3 Pudendal nerve injury 4-6 Stroke, Alzheimer s disease, or Parkinson s disease 1 1. Lue TF. N Engl J Med. 2000;342:1802-1813. 2. NIH Consensus Development Panel on Impotence. JAMA. 1994;270:83-90. 3. Romeo JH, et al. J Urol. 2000;163:788-791. 4. Lewis RW. Urol Clin North Am. 2001;28:209-216. 5. Cherington M. Semin Neurol. 2000;20:247-253. 6. Ricchiuti VS, et al. J Urol. 1999;162:2099-2100.

Causes of ED: Vascular Factors Atherosclerosis 1-3 and associated risk factors 4-7 Smoking 4,6 Diabetes 5 Dyslipidemia 5 Hypertension 5 Obesity 7 Venous leaks 8,9 Pelvic or perineal trauma 10 Perineal arterial compression from cycling 9,10 1. Miller TA. Am Fam Physician. 2000;61:95-104, 109-110. 2. NIH Consensus Development Panel on Impotence. JAMA. 1994;270:83-90. 3. Azadzoi KM, et al. J Urol. 1998;160:2216-2222. 4. Kaiser FE, et al. J Am Geriatr Soc. 1988;36:511-519. 5. Lue TF. N Engl J Med. 2000;342:1802-1813. 6. McVary KT, et al. J Urol. 2001;166:1624-1632. 7. Esposito K, et al. JAMA. 2004;291:2978-2984. 8. Munarriz RM, et al. J Urol. 1995;153:1831-1840. 9. DePalma RG, et al. J Vasc Surg. 1989;10: 117-121. 10. Sommer F, et al. Eur Urol. 2001;39:720-723.

Causes of ED: Hormonal Factors Hypogonadism 1,2 Hypothyroidism, hyperthyroidism 1,3 Pituitary tumor, hyperprolactinemia 1,4 1. AACE Male Sexual Dysfunction Task Force. Endocr Pract. 2003;9:77-95. 2. Morales A, Heaton JP. Urol Clin North Am. 2001;28:279-288. 3. Lue TF. N Engl J Med. 2000;342:1802-1813. 4. Johri AM, et al. Int J Impot Res. 2001;13:176-182.

Intracavernosal Injections PGE 1 (Caverject, Edex) 60% to 70% success rate Penile pain Combination therapy Up to 90% success rate Minimal incidence of penile pain Is there an intrinsic advantage to PGE 1? Intracavernosal injection (ICI) is the treatment modality used in Montorsi study Pain reduction maneuvers Change in formulation Nonsteroidal anti-inflammatory agent Local anesthetic Montorsi F, et al. J Urol. 1997;158:1408-1410.

Penile Injection Therapy Smooth muscle relaxing medication injected directly into the penis (papaverine, phentolamine, PGE 1 )

Oral Medications Viagra Cialis Tadalafil Vardenafil

Results 14 of 51 (27%) patients receiving sildenafil experienced return of spontaneous functional erections (IIEF 3+4=8) 1 of 25 (4%) in the placebo group (P=0.0156) Sildenafil may improve long-term return of functional erections Mechanisms? Oxygenation during nocturnal erections Endothelium protection (DeSouza et al, Diabetes Care, 2002) Neuronal regeneration (Zhang et al, Stroke, 2002)

Penile Injection Therapy: Advantages Highly effective Mimics natural physiology of erection No effect on sensation, ejaculation, fertility Higher level of discretion, thus spontaneity

Penile Prosthesis Pros High patient satisfaction rate 7 to 10 years average functional prosthesis life Higher spontaneity Discreet, normal appearance Erection longevity controllable Significant clinical data on procedure and results

Penile Prosthesis (cont d) Cons Potential for infection, device malfunction Major surgery, postoperative pain, irreversible Additional surgery at product end-of-life Potential decreased sensation, glans sensitivity, ability to ejaculate/reach orgasm Complications include infection, device malfunction, need for additional surgical procedures

Penile Prostheses Some workers suggest prosthesis placement during RP in men with poor preoperative erectile function Preoperative ICI challenge Staged approach No documented increased incidence of prosthetic infection with this approach Timing of implant surgery following RP?

Male Incontinence

Indications for Male Sling Mild to Moderate Incontinence Sphincteric Incompetence Post-Surgical Incontinence Radical prostatectomy TURP Congenital disorders Myelomeningocele (adults only) Sacral agenesis

Male Sling

AMS Sphincter 800

AMS Sphincter 800: Components

AMS Sphincter 800 The device is implanted in the body and cannot be seen. The cuff can be placed at the bulbous urethra or at the bladder neck. The Sphincter allows the patient to control his/her urinary function.

AMS Sphincter 800: Mechanism of Action

AMS Sphincter 800: Mechanism of Action

AMS Sphincter 800: Mechanism of Action

Occlusive Cuff Pressure Regulating Balloon

Patient Selection Criteria Sterile Urine Incontinence due to an incompetent external sphincter Adequate manual dexterity Incontinence present for at least 6 months Bladder capacity of at least 200cc Motivated patient Urine flow greater than 10ml/sec Low residuals

Contraindications Chronic urinary tract infections An irreversibly obstructed urinary tract Patients with low-volume detrusor hyperreflexia Unstable urethral stricture disease or a urethral diverticulum at the potential cuff site Females with SUI due to hypermobility and descent of the bladder neck and proximal urethra

AMS Sphincter 800 Results 90% of male patients reported satisfaction with the AMS Sphincter 800. 80% of males were socially continent using 0-1 pad per day at 7 years. 92% of male patients would have the AMS Sphincter 800 placed again. For over 25 years, the AMS Sphincter 800 has been the gold standard to treat urinary incontinence.

The best interest of the patient is the only interest to be considered. William J. Mayo, M.D. 1861-1939